Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valarmathy Murugaiah

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Frontiers in Oncology|July 30, 2019
Human SP-D Acts as an Innate Immune Surveillance Molecule Against Androgen-Responsive and Androgen-Resistant Prostate Cancer CellsGargi Thakur, Gagan Prakash, Vedang Murthy, et al.
Frontiers in Immunology|August 22, 2017
Protein-Protein Interaction between Surfactant Protein D and DC-SIGN <i>via</i> C-Type Lectin Domain Can Suppress HIV-1 TransferEswari Dodagatta-Marri, Daniel A Mitchell, Hrishikesh Pandit, et al.
Immunobiology|April 8, 2019
Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivityAhmed A Al-Qahtani, Valarmathy Murugaiah, Hani A Bashir, et al.
Frontiers in Immunology|August 15, 2018
Entry Inhibition and Modulation of Pro-Inflammatory Immune Response Against Influenza A Virus by a Recombinant Truncated Surfactant Protein DMohammed N Al-Ahdal, Valarmathy Murugaiah, Praveen M Varghese, et al.
Frontiers in Immunology|August 15, 2022
Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammationNazar Beirag, Chandan Kumar, Taruna Madan, et al.
Frontiers in Immunology|January 25, 2021
C4b Binding Protein Acts as an Innate Immune Effector Against Influenza A VirusPraveen M Varghese, Valarmathy Murugaiah, Nazar Beirag, et al.
Frontiers in Immunology|August 1, 2020
Hyaluronic Acid Present in the Tumor Microenvironment Can Negate the Pro-apototic Effect of a Recombinant Fragment of Human Surfactant Protein D on Breast Cancer CellsValarmathy Murugaiah, Chiara Agostinis, Praveen M Varghese, et al.
Frontiers in Immunology|April 10, 2020
Complement-Independent Modulation of Influenza A Virus Infection by Factor HValarmathy Murugaiah, Praveen M Varghese, Soad M Saleh, et al.
Frontiers in Microbiology|November 29, 2023
A self-amplifying RNA vaccine provides protection in a murine model of bubonic plagueRobin John Shattock, Voahangy Andrianaivoarimanana, Paul F McKay, et al.
Immunobiology|September 15, 2019
Secretion of functionally active complement factor H related protein 5 (FHR5) by primary tumour cells derived from Glioblastoma Multiforme patientsSyreeta DeCordova, Amr Abdelgany, Valarmathy Murugaiah, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|July 30, 2019
Human SP-D Acts as an Innate Immune Surveillance Molecule Against Androgen-Responsive and Androgen-Resistant Prostate Cancer CellsGargi Thakur, Gagan Prakash, Vedang Murthy, et al.
Frontiers in Immunology|August 22, 2017
Protein-Protein Interaction between Surfactant Protein D and DC-SIGN <i>via</i> C-Type Lectin Domain Can Suppress HIV-1 TransferEswari Dodagatta-Marri, Daniel A Mitchell, Hrishikesh Pandit, et al.
Immunobiology|April 8, 2019
Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivityAhmed A Al-Qahtani, Valarmathy Murugaiah, Hani A Bashir, et al.
Frontiers in Immunology|August 15, 2018
Entry Inhibition and Modulation of Pro-Inflammatory Immune Response Against Influenza A Virus by a Recombinant Truncated Surfactant Protein DMohammed N Al-Ahdal, Valarmathy Murugaiah, Praveen M Varghese, et al.
Frontiers in Immunology|August 15, 2022
Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammationNazar Beirag, Chandan Kumar, Taruna Madan, et al.
Frontiers in Immunology|January 25, 2021
C4b Binding Protein Acts as an Innate Immune Effector Against Influenza A VirusPraveen M Varghese, Valarmathy Murugaiah, Nazar Beirag, et al.
Frontiers in Immunology|August 1, 2020
Hyaluronic Acid Present in the Tumor Microenvironment Can Negate the Pro-apototic Effect of a Recombinant Fragment of Human Surfactant Protein D on Breast Cancer CellsValarmathy Murugaiah, Chiara Agostinis, Praveen M Varghese, et al.
Frontiers in Immunology|April 10, 2020
Complement-Independent Modulation of Influenza A Virus Infection by Factor HValarmathy Murugaiah, Praveen M Varghese, Soad M Saleh, et al.
Frontiers in Microbiology|November 29, 2023
A self-amplifying RNA vaccine provides protection in a murine model of bubonic plagueRobin John Shattock, Voahangy Andrianaivoarimanana, Paul F McKay, et al.
Immunobiology|September 15, 2019
Secretion of functionally active complement factor H related protein 5 (FHR5) by primary tumour cells derived from Glioblastoma Multiforme patientsSyreeta DeCordova, Amr Abdelgany, Valarmathy Murugaiah, et al.
Pageof 3